Capricor Therapeutics to Host Key Opinion Leader Call on Cardiac Complications of Duchenne Muscular Dystrophy

NEXT STORY
Quantum Materials Announces QDX™ HealthID to Support Back-to-Work “Immunization Passport” Programs
PREV STORY
Alimera Sciences Pre-Announces Expected Top Line Revenue for Q1 2020 and Provides COVID-19 Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose to Present at the 17th Annual Biotech in Europe Forum

SAN DIEGO, and TORONTO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) ...

author_avatar
NASDAQ Market News

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test

MIAMI, May 18, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq:OPK) today announced that ...

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Announces Non-Binding Term Sheet Signed with Global Pharmaceutical Company to Develop and Commercialize Brilacidin for the Treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis

author_avatar
NASDAQ Market News